Literature DB >> 7726622

Jet nebulising systems for recombinant human DNase I.

J C Hung, G Hambleton, M Super.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7726622      PMCID： PMC1030101          DOI： 10.1136/adc.71.6.558-a

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  4 in total

1.  Drug delivery from jet nebulisers.

Authors:  M L Everard; A R Clark; A D Milner
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

2.  Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis.

Authors:  C Ranasinha; B Assoufi; S Shak; D Christiansen; H Fuchs; D Empey; D Geddes; M Hodson
Journal:  Lancet       Date:  1993-07-24       Impact factor: 79.321

3.  Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern.

Authors:  S P Newman; G Woodman; S W Clarke
Journal:  Thorax       Date:  1988-04       Impact factor: 9.139

4.  Crystalline desoxyribonuclease; isolation and general properties; spectrophotometric method for the measurement of desoxyribonuclease activity.

Authors:  M KUNITZ
Journal:  J Gen Physiol       Date:  1950-03       Impact factor: 4.086
  4 in total
  2 in total

Review 1.  Nebulizers in cystic fibrosis.

Authors:  G Hambleton; J C Hung; M Super
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

2.  Selecting and using nebuliser equipment.

Authors:  A H Kendrick; E C Smith; R S Wilson
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.